Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ovation epilepsy therapy effective in study
Lennox-Gastaut syndrome is one of the most severe forms of childhood epilepsy. This form of catastrophic epilepsy, characterized by several seizure types, represents up to 10% of all
Lennox-Gastaut syndrome is one of the most severe forms of childhood epilepsy. This form of catastrophic epilepsy, characterized by several seizure types, represents up to 10% of all
“The progression of this therapeutic candidate is an example of Xanthus' commitment to the development of products that address hematological malignancies that pose an unmet medical need,” stated
Regadenoson is a selective A2A-adenosine receptor agonist for potential use as a pharmacologic stress agent in myocardial perfusion imaging (MPI) studies. A prior identically designed phase III study,
The phase III trial evaluated Nexavar when administered in combination with a standard dosing schedule of the chemotherapy drugs, carboplatin and paclitaxel. The study was designed to measure
The agreement does not include Japan, which is yet to be partnered. In exchange for development and commercialization rights, AstraZeneca has agreed to pay Cubist $10.25 million cash
The study was a phase II safety, efficacy and absorption evaluation of ARYS-01 cream with the test material applied twice daily for 7 days in patients with a
The key to boosting the vaccines is by extending the lives of dendritic cells, the immune-system master switches that promote the response of T-cells, which attack tumors. “By
In early trading Pfizer’s shares fell more than 10% in Frankfurt. A monitoring board recommended terminating the study because of an imbalance of mortality and cardiovascular events. Patient
The risk of heart attack can be reduced by more than 50% by combining a cholesterol-reducing drug, atorvastatin calcium, with a blood pressure-lowering drug amlodipine besylate, a calcium
New data from a phase II trial of patients with Crohn’s disease analyzed the effect of Traficet-EN on lowering pro-inflammatory cytokine and chemokine concentrations in the intestine. These